Regulus Therapeutics Inc (NASDAQ:RGLS)

0.6534
Delayed Data
As of Apr 20
 -0.0062 / -0.94%
Today’s Change
0.63
Today|||52-Week Range
1.95
-37.17%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Regulus Therapeutics Inc have a median target of 1.50, with a high estimate of 3.00 and a low estimate of 1.00. The median estimate represents a +129.57% increase from the last price of 0.65.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Hold stock in Regulus Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.13
Sales
$10.6M
Reporting Date
May 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 8.93%
 
 
 
 
 
 
Growthannually 41.22%
 
 
 
 
 
 

Sales

Growthquarterly 58,788.89%
 
 
 
 
 
 
Growthannually -76.85%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.